Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2020

Jun 16, 2020

30786_dirs_2020-06-15_a2baf6a8-045d-4af5-915a-b7e2d52cd3e7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2020-06-12

Reporting Person: SCHWARTZ NORMAN D (Director, Chairman, President, and CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-06-12 Bio-Rad B Common Stock M 37000 $84.57 Acquired 316982 Direct
2020-06-12 Bio-Rad B Common Stock F 21860 $448.85 Disposed 295122 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-06-12 Non-Qualified Stock Option (right to buy) $84.57 M 37000 Disposed 2020-09-08 Bio-Rad B Common Stock (37000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 415182 Direct
Bio-Rad B Common Stock 12811 Indirect
Bio-Rad B Common Stock 4060054 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of these shares.

F2: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: The option vested in five equal annual installments beginning on September 8, 2011.